The AHSN Network has supported many innovators to help advance our health and care system. Find out more about successful innovations supported by the NHS.
Quick, accurate blood tests which can help rule out pre-eclampsia are improving care for pregnant women and their unborn babies, reducing anxiety and saving the NHS money. AHSNs are leading a rapid adoption project for these tests into maternity units across the country.
New artificial intelligence (AI)-driven imaging support software which has the potential to deliver huge benefits to hundreds of stroke patients each year and significant cost savings to the NHS has been implemented at the Royal Berkshire NHS Foundation Trust (RBH). The Oxford AHSN is supporting wider regional roll-out backed by NHS England. The CE-marked e-Stroke Suite developed by Brainomix Ltd includes tools for non-contrast CT and CT angiography brain scans, connecting physicians and facilitating information transfer. The software supports physicians in identifying patients who would benefit from acute stroke treatments, selecting patients most likely to benefit from specific interventions, such as mechanical thrombectomy.
Stroke affects 100,000 people in the UK each year . 33% of patients will die and 90% of survivors will have a disability for the rest of their lives.
This service improvement programme aims to enable primary care staff to improve lower limb vascular assessments in patients with leg ulcers to allow appropriate treatment to start earlier.
Guy’s and St Thomas’ YES programme gives 14-19 year-olds in south London the support they need to live with Type 1 diabetes. Participants meet other young people with Type 1 diabetes, building confidence and developing a peer support network. Learn how the Health Innovation Network (HIN) supported the programme to scale up from one London borough to twelve.
We are supporting three rheumatology departments across south east London (SEL) to trial a new service that supports patients with rheumatoid arthritis (RA) to remotely monitor their condition. The service aims to help people access the care they need, when they most need it, rather than rely on routine appointments.
RefuAid is a charity that sources and supports refugee healthcare professionals to work in the NHS.www.refuaid.org
The HIN engaged with OPUS and commissioned them on a pro bono basis to adapt their existing comprehensive guidance to ensure care home staff were aware of how to safely administer medicines without using a dosette box during the pandemic.
A registered clinical device, the Compass Point of Care AKI & HAP app is a tool providing augmented intelligence in the form of decision support algorithms to support the early intervention and prevention of acute kidney injury (AKI) and hospital-acquired pneumonia. Use of this app is proven by published clinical trials and real-world use within NHS and international healthcare systems to reduce both conditions in hospitals by up to 60%. The app delivers benefits to both COVID and non-COVID patients and is available to download for IOS and Android devices.
Gendius developed product Intellin® is an intelligent diabetes management platform that uses clinical data to predict the trajectory of an individual's diabetes and helps to mitigate progression through smart tips. Powered by sophisticated AI algorithms, Intellin® is changing the way diabetes is managed. The Intellin® App is today the fastest downloaded diabetes app in the world.
We work in the field of EPRR – emergency preparedness, planning, risk and resilience Adjutant are different due to our experience and deep knowledge comes from decades of front line service responding to critical situations and incidents in the military and blue light services.Unfortunately we have witnessed personally critical deficiencies in the implementation and execution of EPRR plans and experienced how poor communication provision can cost lives.So we decided to do something about it
Early detection of melanoma is crucial for disease prognosis and survival rate. The Primary Care Innovations Programme has partnered with Gnosco to implement and evaluate the Dermicus teledermatology Platform across all GP locations on the Isle of Wight.
